Punt CJ - Search Results

1

A pilot study on the immunogenicity of dendritic cell vaccination during adjuvant oxaliplatin/capecitabine chemotherapy in colon cancer patients.

Lesterhuis WJ, de Vries IJ, Aarntzen EA, de Boer A, Scharenborg NM, van de Rakt M, van Spronsen DJ, Preijers FW, Figdor CG, Adema GJ, Punt CJ. Lesterhuis WJ, et al. Among authors: punt cj. Br J Cancer. 2010 Oct 26;103(9):1415-21. doi: 10.1038/sj.bjc.6605935. Epub 2010 Oct 5. Br J Cancer. 2010. PMID: 20924373 Free PMC article.

2

Continuous infusion of high-dose 5-fluorouracil in combination with leucovorin and recombinant interferon-alpha-2b in patients with advanced colorectal cancer. A Multicenter Phase II study.

Punt CJ, Burghouts JT, Croles JJ, van Liessum PA, de Mulder PH, Kamm Y. Punt CJ, et al. Cancer. 1993 Oct 1;72(7):2107-11. doi: 10.1002/1097-0142(19931001)72:7<2107::aid-cncr2820720708>3.0.co;2-m. Cancer. 1993. PMID: 8374869 Clinical Trial.

3

Tallimustine in advanced previously untreated colorectal cancer, a phase II study.

Punt CJ, Humblet Y, Roca E, Dirix LY, Wainstein R, Polli A, Corradino I. Punt CJ, et al. Br J Cancer. 1996 Mar;73(6):803-4. doi: 10.1038/bjc.1996.140. Br J Cancer. 1996. PMID: 8611384 Free PMC article. Clinical Trial.

4

Chemoimmunotherapy with bleomycin, vincristine, lomustine, dacarbazine (BOLD) plus interferon alpha for metastatic melanoma: a multicentre phase II study.

Punt CJ, van Herpen CM, Jansen RL, Vreugdenhil G, Muller EW, de Mulder PH. Punt CJ, et al. Br J Cancer. 1997;76(2):266-9. doi: 10.1038/bjc.1997.374. Br J Cancer. 1997. PMID: 9231931 Free PMC article. Clinical Trial.

5

Phase IB study of doxorubicin in combination with the multidrug resistance reversing agent S9788 in advanced colorectal and renal cell cancer.

Punt CJ, Voest EE, Tueni E, Van Oosterom AT, Backx A, De Mulder PH, Hecquet B, Lucas C, Gerard B, Bleiberg H. Punt CJ, et al. Br J Cancer. 1997;76(10):1376-81. doi: 10.1038/bjc.1997.563. Br J Cancer. 1997. PMID: 9374386 Free PMC article. Clinical Trial.

6

5-Fluorouracil in colorectal cancer: rationale and clinical results of frequently used schedules.

Kamm YJ, Wagener DJ, Rietjens IM, Punt CJ. Kamm YJ, et al. Among authors: punt cj. Anticancer Drugs. 1998 Jun;9(5):371-80. doi: 10.1097/00001813-199806000-00001. Anticancer Drugs. 1998. PMID: 9660532 Review.

7

New drugs in the treatment of colorectal carcinoma.

Punt CJ. Punt CJ. Cancer. 1998 Aug 15;83(4):679-89. doi: 10.1002/(sici)1097-0142(19980815)83:4<679::aid-cncr8>3.0.co;2-f. Cancer. 1998. PMID: 9708931 Review.

8

Biodistribution and vaccine efficiency of murine dendritic cells are dependent on the route of administration.

Eggert AA, Schreurs MW, Boerman OC, Oyen WJ, de Boer AJ, Punt CJ, Figdor CG, Adema GJ. Eggert AA, et al. Among authors: punt cj. Cancer Res. 1999 Jul 15;59(14):3340-5. Cancer Res. 1999. PMID: 10416590

9

Melanoma-inhibiting activity (MIA) mRNA is not exclusively transcribed in melanoma cells: low levels of MIA mRNA are present in various cell types and in peripheral blood.

de Vries TJ, Fourkour A, Punt CJ, Diepstra H, Ruiter DJ, van Muijen GN. de Vries TJ, et al. Among authors: punt cj. Br J Cancer. 1999 Nov;81(6):1066-70. doi: 10.1038/sj.bjc.6690808. Br J Cancer. 1999. PMID: 10576666 Free PMC article.

10

[Immunology in medical practice. XXV. Use of dendritic cells in the immunotherapy of cancer].

Punt CJ, de Vries IJ, Mulders PF, Adema GJ, Figdor CG. Punt CJ, et al. Ned Tijdschr Geneeskd. 1999 Nov 27;143(48):2408-14. Ned Tijdschr Geneeskd. 1999. PMID: 10608974 Review. Dutch.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

496 results

Search Page

Filters